InAADR

Drug Information

Drug Name: Nafronyl (31329-57-4)
PubChem ID: 4417
SMILES: CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32
InchiKey: KBAFPSLPKGSANY-UHFFFAOYSA-N
Therapeutic Category: Cardiovascular Agents, Neurotransmitter Agents, Serotonin Agents, Serotonin Antagonists, Vasodilator Agents

Computed Drug Properties

Molecular Weight (dalton): 383.532
LogP: 4.4526
Ring Count: 2
Hydrogen Bond Acceptor Count: 4
Hydrogen Bond Donor Count: 0
Total Polar Surface Area: 38.77

This panel provides information on interacting drugs and their ADRs along with references

Interacting drug Toxicity Interaction Type Mechanism Reference

This panel provides drug-protein interaction and their ADRs along with references

Toxicity Interacting Protein Mechanism Reference

This panel provides drug-food interactions and their ADRs along with references

Food Toxicity Reference

This panel provides information on metabolites and their ADRs along with references

Metabolite Toxicity Place of Metabolism Mechanism Reference

This panel provides information on drug category

Toxicity Source
Abnormal Behaviour MetaADEDB
Abnormal Eeg MetaADEDB
Acidosis MetaADEDB
Acute Generalised Exanthematous Pustulosis MetaADEDB
Acute Kidney Failure MetaADEDB
Aggression MetaADEDB
Agranulocytoses MetaADEDB
Allergic Dermatitis MetaADEDB
Amnesia MetaADEDB
Antinuclear Antibody MetaADEDB
Antiviral Drug Level Above Therapeutic MetaADEDB
Apathy MetaADEDB
Arterial Stenosis MetaADEDB
Atrial Tachycardia MetaADEDB
Atrioventricular Block Complete MetaADEDB
Aura MetaADEDB
Benign Pancreatic Neoplasm MetaADEDB
Bicytopenia MetaADEDB
Bile Duct Obstruction MetaADEDB
Black Stools MetaADEDB
Bladder Inflammation MetaADEDB
Bleb MetaADEDB
Blood Creatinine Increased MetaADEDB
Blood Lactate Dehydrogenase Increased MetaADEDB
Blood Sodium MetaADEDB
Blood Sodium Increased MetaADEDB
Brain Natriuretic Peptide Increased MetaADEDB
Brain Oedema MetaADEDB
Bronchiolitis MetaADEDB
C-Reactive Protein Increased MetaADEDB
Cardiac Failure MetaADEDB
Cardiac Murmur MetaADEDB
Cardio-Respiratory Arrest MetaADEDB
Cardio-Respiratory Distress MetaADEDB
Cardioactive Drug Level Increased MetaADEDB
Cardiogenic Shock MetaADEDB
Cartilage Development Disorder MetaADEDB
Cerebral Atrophy MetaADEDB
Chemotherapeutic Drug Level Increased MetaADEDB
Chill MetaADEDB
Cholangiolitis MetaADEDB
Circumstance Or Information Capable Of Leading To Medication Error MetaADEDB
Clostridium Difficile Colitis MetaADEDB
Confabulation MetaADEDB
Crackles Lung MetaADEDB
Creatinine Renal Clearance Decreased MetaADEDB
Cutaneous Vasculitis MetaADEDB
Cytolytic Hepatitis MetaADEDB
Dehydration MetaADEDB
Dermatitis Bullous MetaADEDB
Dermatitis Exfoliative MetaADEDB
Detached Retina MetaADEDB
Diagnostic Procedure MetaADEDB
Disorder Lung MetaADEDB
Drowsiness MetaADEDB
Drug Administration Error MetaADEDB
Drug Dispensing Error MetaADEDB
Drug Interaction MetaADEDB
Drug Resistance MetaADEDB
Duodenal Ulcer Perforation MetaADEDB
Dyspnoea At Rest MetaADEDB
Eczema MetaADEDB
Edema Extremities MetaADEDB
Ejection Fraction Decreased MetaADEDB
Electrocardiogram Qt Prolonged MetaADEDB
Elevated Triglycerides MetaADEDB
Enterocolitis MetaADEDB
Eosinophil Count Increased MetaADEDB
Excess Potassium MetaADEDB
Eye Rolling MetaADEDB
Febrile Infection MetaADEDB
Gallbladder Enlargement MetaADEDB
Gastrointestinal Bleed MetaADEDB
Gastrointestinal Motility Disorder MetaADEDB
Gastrointestinal Ulcer Perforation MetaADEDB
General Physical Health Deterioration MetaADEDB
Granulocytosis MetaADEDB
Haematemesis MetaADEDB
Haematoma MetaADEDB
Haemophilus Infection MetaADEDB
Heart Injury MetaADEDB
Henoch-Schonlein Purpura MetaADEDB
Hepatitis MetaADEDB
Hepatitis Non-A Non-B MetaADEDB
Hepatocellular Damage MetaADEDB
Hepatojugular Reflux MetaADEDB
Hernia Inguinal MetaADEDB
Hot Flash MetaADEDB
Hyperaesthesia MetaADEDB
Hyperhidrosis MetaADEDB
Hypoalbuminaemia MetaADEDB
Hypoglycaemia Neonatal MetaADEDB
Hypoglycaemic Unconsciousness MetaADEDB
Hypophosphataemia MetaADEDB
Idiopathic Thrombocytopenic Purpura MetaADEDB
Increased White Blood Cell Count MetaADEDB
Infrequent Bowel Movements MetaADEDB
Intention Tremor MetaADEDB
Intentional Misuse MetaADEDB
International Normalised Ratio Increased MetaADEDB
Itch MetaADEDB
Kidney Failure MetaADEDB
Large Intestine Perforation MetaADEDB
Leukoencephalopathy MetaADEDB
Lymphocytes Decreased MetaADEDB
Memory Disorders MetaADEDB
Meningitis Bacterial MetaADEDB
Motor Neurone Disease MetaADEDB
Motor Retardation MetaADEDB
Movement Disorder MetaADEDB
Multiple Drug Overdose MetaADEDB
Oesophageal Candidiasis MetaADEDB
Oesophagitis Ulcerative MetaADEDB
Overdose MetaADEDB
Peritoneal Effusion MetaADEDB
Personality Change MetaADEDB
Phlebitis MetaADEDB
Platelet Count MetaADEDB
Pneumoperitoneum MetaADEDB
Polymyositis MetaADEDB
Potentiating Drug Interaction MetaADEDB
Proctitis MetaADEDB
Prothrombin Time Prolonged MetaADEDB
Psychogenic Pain Disorder MetaADEDB
Puva MetaADEDB
Pyelonephritis MetaADEDB
Self-Medication MetaADEDB
Status Epilepticus MetaADEDB
Stent Occlusion MetaADEDB
Sternal Fracture MetaADEDB
Subileus MetaADEDB
Superficial Thrombophlebitis MetaADEDB
Thrombosis In Device MetaADEDB
Torsade De Pointes MetaADEDB
Toxic Skin Eruption MetaADEDB
Transmission Of An Infectious Agent Via A Medicinal Product MetaADEDB
Vaginal Prolapse MetaADEDB
Vascular Operation MetaADEDB

InAADR: Drug-Protein-ADRs database